Kinnevik AB (SE:KINV.B)
:KINV.B
Want to see SE:KINV.B full AI Analyst Report?
Earnings Data
Report Date
Jul 14, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
2.26Same Quarter Last Year
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call balanced stark valuation-driven setbacks with clear, deliberate management actions to preserve optionality and improve operational efficiency. Q1 was marked by substantial market-driven write-downs (NAV -22%, private -29%, SEK 8.3bn multiple impact) and the strategic withdrawal from Climate Tech. Offsetting these negatives, portfolio companies showed healthy top-line growth and margin improvements (health +28% revenue, software +32% revenue), a clinical milestone at Enveda, a strong cash position (SEK 7.5bn) and concrete plans to reduce management cash costs by ~35% to SEK 200m and cap follow-on spend at SEK 1.5bn, leaving an estimated SEK 5bn discretionary capacity. Given the significant valuation losses tempered by decisive capital-preservation and operational actions, the overall tone is cautious but constructive — management is responding with concrete levers while acknowledging material near-term headwinds.Company Guidance
Strong Q1 revenue and margin progress at larger investees
Health investees grew revenues by 28% year-over-year in Q1 and improved EBITDA margins by 3 percentage points; software investees grew revenues by 32% and improved margins by 7 percentage points, indicating solid operational execution across core portfolio companies.
Enveda clinical milestone
Enveda completed a Phase Ib study for its lead drug candidate showing efficacy above current standard of care and clear safety/tolerability signals; company progressing to Phase II, representing a material value-creating milestone in the Health & Bio cluster.
Strong liquidity position and discretionary capacity
Kinnevik held SEK 7.5 billion in cash at quarter-end and expects to preserve cash to deliver roughly SEK 5 billion in discretionary investment capacity for the next CEO (after reserving ~SEK 1.0 billion for 5 years of management cash cost and capping follow-ons at SEK 1.5 billion).
Targeted cost reduction to improve stewardship of capital
Management cash cost baseline for 2025 was SEK 313 million (after removing non-cash items). Management targets SEK 200 million annual management cash cost (steady-state) — a ~35% reduction — with restructuring costs to be taken primarily in 2026 and target reached by 2027.
Disciplined follow-on capital policy
Board/management set a cap of no more than SEK 1.5 billion for follow-on investments in the existing portfolio (described as a cap rather than a budget) to preserve optionality and limit cash deployment into follow-ons.
Execution of capital allocation and selective investment
Q1 activity included completion of EUR 20 million participation in Mews' funding round; net investments in the quarter were SEK 116 million (after a real estate sale), keeping net cash largely unchanged at SEK 7.5 billion.
Improved reporting transparency and NAV detail
Reporting length reduced from ~40 to ~20 pages; NAV disclosure expanded to include last-transaction values and a historical pro forma NAV overview under the new sector categorization to enhance transparency.
Transaction evidence supporting valuations
Over the last 12 months, transactions covered ~46% of private portfolio by value, at a weighted average premium of 9% to the preceding NAV assessment — indicating continued market activity and validation points for valuations.
SE:KINV.B Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:KINV.B Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 16, 2026 | kr53.88 | kr55.22 | +2.49% |
Feb 03, 2026 | kr74.00 | kr70.48 | -4.76% |
Oct 16, 2025 | kr82.60 | kr89.62 | +8.50% |
Jul 08, 2025 | kr84.14 | kr91.32 | +8.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Kinnevik AB (SE:KINV.B) report earnings?
Kinnevik AB (SE:KINV.B) is schdueled to report earning on Jul 14, 2026, Before Open (Confirmed).
What is Kinnevik AB (SE:KINV.B) earnings time?
Kinnevik AB (SE:KINV.B) earnings time is at Jul 14, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Kinnevik AB stock?
The P/E ratio of Kinnevik AB is N/A.
What is SE:KINV.B EPS forecast?
Currently, no data Available